USE OF MELATONIN IN THE TREATMENT OF SLEEP DISORDERS IN PATIENTS WITH PARKINSON’S DISEASE
The paper analyzes the causes and clinical manifestations of sleep and awakening disorders in Parkinson’s disease, describes clinical cases with dyssomnia at the early and extensive stages of the disease and the efficiency of using melatonin to normalize circadian rhythm.
Saved in:
| Main Authors: | E. N. Gubanova, N. V. Fedorova |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2014-07-01
|
| Series: | Klinicist |
| Subjects: | |
| Online Access: | https://klinitsist.abvpress.ru/Klin/article/view/15 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
SLEEP DISORDERS IN NEUROLOGICAL PRACTICE: A ROLE OF MELATONIN IN THERAPY FOR PRIMARY SLEEP AND AWAKENING DISORDERS IN PATIENTS WITH PARKINSON’S DISEASE
by: N. V. Fedorova, et al.
Published: (2014-07-01) -
Melatonin attenuates MPP+-induced autophagy via heat shock protein in the Parkinson’s disease mouse model
by: Yinli Guo, et al.
Published: (2025-01-01) -
USE OF EXTENDED-RELEASE PRAMIPEXOLE IN EARLY-STAGE PARKINSON’S DISEASE: DESCRIPTION OF A CLINICAL CASE
by: N. V. Fedorova, et al.
Published: (2014-11-01) -
A modern view on potential biomarkers of Parkinson’s disease (review)
by: A. V. Demchenko, et al.
Published: (2020-08-01) -
Regulatory aspects and evidences of melatonin use for sleep disorders and insomnia: an integrative review
by: Ana Paula Rosinski Bueno, et al.
Published: (2021-09-01)